Skip to main content
MedPath Trial logoMedPath TrialMedPath Trial Home
Clinical Trials/ChiCTR2000029437
ChiCTR2000029437Not yet recruitingNot Applicable

中西医结合治疗新型冠状病毒肺炎(COVID-19)的单队列研究

国家科技部1 site in 1 country300 target enrollmentStarted: February 1, 2020Last updated:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Not yet recruiting
Sponsor
Enrollment
300
Locations
1
Primary Endpoint
所有可获得的临床检查指标
Study OverviewStudy DesignEligibility CriteriaArms & InterventionsOutcomesInvestigatorsSitesRecords & IdentifiersSimilar Trials

Study Overview

Brief Summary

在临床实际诊疗条件下，中西医结合方案对新型冠状病毒感染的肺炎不同程度患者的疗效。

Study Design

Study Type
观察性研究
Primary Purpose
单臂
Masking
N/a

Eligibility Criteria

Sex
All

Inclusion Criteria

  • •确诊为新型冠状病毒感染的肺炎的住院患者。

Exclusion Criteria

  • •医生判断不适合参加研究。

Arms & Interventions

观察组

根据指南要求治疗

Intervention: 根据指南要求治疗

Outcomes

Primary Outcomes

所有可获得的临床检查指标

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor
国家科技部

Study Sites (1)

Loading locations...

Similar Trials

Unknown
Not Applicable
中西医结合治疗方案对普通型新型冠状病毒肺炎(COVID-19)的临床随机对照研究新型冠状病毒肺炎(COVID-19)
ChiCTR2000029461自筹100
Unknown
Not Applicable
中西医防治新型冠状病毒感染肺炎(COVID-19)的临床研究新型冠状病毒感染肺炎(COVID-19)
ChiCTR2000029751科技厅拨款350
Unknown
Not Applicable
中西医结合干预新型冠状病毒肺炎(COVID-19)临床评价研究新型冠状病毒感染肺炎(COVID-19)
ChiCTR2000030315吉林省科技厅120
Unknown
Not Applicable
新型冠状病毒肺炎(COVID-19)中西医结合治疗方案的疗效评价新型冠状病毒肺炎(COVID-19)
ChiCTR20000294362020 年新型冠状病毒防控应急攻关项目（201100310500）100
Unknown
Not Applicable
中西医结合治疗普通型新型冠状病毒肺炎(COVID-19)临床试验新型冠状病毒肺炎(COVID-19)
ChiCTR2000029439国家科技部120